PTPRC and cystic fibrosis: AI-assisted quantification of α-SMA and CD45 PA was challenging in post mortem CF donors due to potential under-staining in comparison with deceased organ donors, disrupted tissue morphology and loss of cellularity with disease progression (ESM Figs 18, 19).